Myth: Alternative nicotine products don't help people stop smoking: Difference between revisions
Jump to navigation
Jump to search
| Line 190: | Line 190: | ||
*Citation: HENNINGFIELD, J. E., FANT, R. V., GITCHELL, J., & SHIFFMAN, S. (2006). Tobacco Dependence: Global Public Health Potential for New Medications Development and Indications. Annals of the New York Academy of Sciences, 909(1), 247–256. doi:10.1111/j.1749-6632.2000.tb06686.x | *Citation: HENNINGFIELD, J. E., FANT, R. V., GITCHELL, J., & SHIFFMAN, S. (2006). Tobacco Dependence: Global Public Health Potential for New Medications Development and Indications. Annals of the New York Academy of Sciences, 909(1), 247–256. doi:10.1111/j.1749-6632.2000.tb06686.x | ||
*Acknowledgement: Portions of this paper were adapted from a paper submitted by these authors to The Economics of Neuroscience. 37 The preparation of this paper was partially supported by unrestricted funding by SmithKline Beecham Consumer Healthcare for which the authors also provide consulting services. | *Acknowledgement: Portions of this paper were adapted from a paper submitted by these authors to The Economics of Neuroscience. 37 The preparation of this paper was partially supported by unrestricted funding by SmithKline Beecham Consumer Healthcare for which the authors also provide consulting services. | ||
<br> | |||
='''Combining Alternative Nicotine Products With Other Quit Smoking Strategies'''= | |||
===2019: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6783661/ Multimodal Smoking Cessation in a Real-Life Setting: Combining Motivational Interviewing With Official Therapy and Reduced Risk Products]=== | |||
*The use of different therapeutic strategies in clinical practice, including pharmacotherapy and nonstandard electronic nicotine delivery systems, such as an electronic cigarette, ensures a greater chance of cessation success and the possibility of tailoring interventions according to patients’ resources. | |||
<br> | <br> | ||
| Line 267: | Line 273: | ||
*Acknowledgement: Research reported in this publication was supported by grant number P50DA036151 from the National Institute on Drug Abuse (NIDA) and FDA Center for Tobacco Products (CTP). | *Acknowledgement: Research reported in this publication was supported by grant number P50DA036151 from the National Institute on Drug Abuse (NIDA) and FDA Center for Tobacco Products (CTP). | ||
<br> | <br> | ||
='''Studies Alternative Nicotine Products- Facilitators and Barriers to Quitting Smoking'''= | ='''Studies Alternative Nicotine Products- Facilitators and Barriers to Quitting Smoking'''= | ||